Case ID: f-appx_504/html/0922-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

CORDIS CORPORATION, Plaintiff-Appellant, v. BOSTON SCIENTIFIC CORPORATION and Boston Scientific Scimed, Inc., Defendants-Appellees.
    No. 2012-1647.
    United States Court of Appeals, Federal Circuit.
    May 13, 2013.
    Constantine L. Trela, Jr., Sidley Austin, LLP, of Chicago, IL, argued for plaintiff-appellant. With him on the brief were David T. Pritikin, William H. Baumgart-ner, Jr., and Anthony Balkissoon. Of counsel was Linda R. Friedlieb.
    Matthew M. Wolf, Arnold & Porter LLP, of Washington, DC, argued for defendants-appellees. With him on the brief were Edward Han, John E. Nilsson and Seth I. Heller.
    Before O’MALLEY, SCHALL, and WALLACH, Circuit Judges.
   PER CURIAM.

We affirm the judgment of the district court without opinion. We vacate, however, the portion of the district court’s decision “nullifying” (invalidating) dependent claims 14-16 of U.S. Patent No. 6,547,817. See Cordis Corp. v. Boston Scientific Corp., 868 F.Supp.2d 342, 356-57 (D.Del.2012).

AFFIRMED IN PART AND VACATED IN PART.